Efficacy and safety of once-daily oxybutynin patch versus placebo and propiverine in Japanese patients with overactive bladder: A randomized double-blind trial-Reference-Cited by-同舟云学术

Efficacy and safety of once-daily oxybutynin patch versus placebo and propiverine in Japanese patients with overactive bladder: A randomized double-blind trial

Published:2013-12-18 Issue:6 Volume:21 Page:586-593
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int J Urol

Author:

Yamaguchi Osamu¹,Uchida Eiji²,Higo Naruhito³,Minami Hidenao³,Kobayashi Shigeo³,Sato Hiroyuki³,

Affiliation:

1. Division of Lower Urinary Tract Dysfunction Research and Bioengineering; Nihon University School of Engineering; Koriyama Japan

2. Office for Promoting Medical Research; Showa University; Tokyo Japan

3. Hisamitsu Pharmaceutical Co., Inc.; Tokyo Japan

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/iju.12372/fullpdf

Reference21 articles.

1. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society;Abrams;Neurourol. Urodyn.,2002

2. Prevalence and burden of overactive bladder in the United States;Stewart;World J. Urol.,2003

3. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study;Milsom;BJU Int.,2001

4. An epidemiological survey of overactive bladder symptoms in Japan;Homma;BJU Int.,2005

5. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS;Milsom;Urology,2012

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of pharmacotherapy on sexual function in female patients being treated for idiopathic overactive bladder: a systematic review;BMC Women's Health;2024-05-16

2. Potential side effects of currently available pharmacotherapies in male lower urinary tract symptoms suggestive of benign prostatic hyperplasia;Expert Opinion on Drug Safety;2023-12-02

3. Comparative assessment of efficacy and safety of approved oral therapies for overactive bladder: a systematic review and network meta-analysis;International braz j urol;2023-10

4. A novel lotion formulation of 20% oxybutynin hydrochloride for the treatment of primary palmar hyperhidrosis: A randomized, placebo-controlled, double-blind, phase III study;Journal of the American Academy of Dermatology;2023-07

5. Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults;Cochrane Database of Systematic Reviews;2023-05-09